Overview

Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus

Status:
Suspended
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
This is a clinical research study of T900607-sodium to determine if it is effective and safe in treating gastric cancer and adenocarcinoma of the esophagus. Patients will be treated on a weekly basis with an intravenous injection of the study drug.
Phase:
Phase 2
Details
Lead Sponsor:
Tularik